Skip to main content
MMedVellum
MCQsExamsAtlas
DashboardPricing
MMedVellum

The exam atlas that feels like a flagship product — evidence-graded topics and exam tools for MBBS and fellowship preparation. Built to scale to fifty specialties. Educational content only — not medical advice.

llms.txt·psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Clinical Atlas Prestige · Evidence-first

Psych VivasSpecialty psychiatry — clinical paraphilic disorders

Psych Vivas · Specialty psychiatry — clinical paraphilic disorders

Paraphilic disorders (clinical) — structured clinical viva

Fellowship viva on clinical exhibitionistic disorder: interest vs disorder, risk, WFSBP ladder, ethics of drive-reduction requests.

clinical
On this page & tools

Target exams

FRANZCPMRCPsychABPNMD-DNB

Target exams

FRANZCPMRCPsychABPNMD-DNB
Prompt
You are the psychiatry registrar in outpatient clinic. A 41-year-old man reports 2 years of exhibitionistic urges on public transport, two episodes of exposing himself while intoxicated, intense shame, and a request for 'medication to kill my sex drive.' He has no known child-related interests. Partner is distressed. Discuss classification, differential, risk, assessment, WFSBP-aligned management including when SSRIs versus antiandrogens/GnRH are considered, monitoring, and communication about goals of care.

Interpretation

Reveal interpretation

This is exhibitionistic disorder (preferred atypical interest with acts involving nonconsenting persons plus distress), with alcohol as facilitator, partner impact, and a request for extreme drive reduction. Priorities: public risk management, substance work, psychological treatment, stepped pharmacology rather than jumping straight to GnRH, and ethical framing of goals.[1][2][7]

Structured viva answer

Reveal model viva answer

1. Classification. Paraphilia = atypical interest; disorder = distress/impairment or nonconsent/harm. Exhibitionistic disorder fits acted-on exposure to unsuspecting persons with distress. Do not pathologise unrelated consensual adult diversity.[1]

2. Differential. CSBD if control failure without exhibitionistic preference; mania/psychosis disinhibition; personality/antisocial facilitation; substance-only episodes; OCD sexual obsessions (not preferred arousal).[1]

3. Risk formulation. Motivation (exhibitionistic interest) + facilitators (alcohol, opportunity on transport, possible self-regulation deficits). Assess recurrence risk, legal status, victim impact, partner safety, suicide/shame risk.[7]

4. Assessment. Permission-based history; substances; MSE; collateral; explain confidentiality limits if ongoing risk to identifiable persons; document carefully.[2][3]

5. Management ladder. Alcohol cessation plan; CBT/relapse prevention; situational control (avoid high-risk contexts while intoxicated). SSRI strategies at antidepressant-class dosing for drive/compulsivity/comorbid mood if indicated. Antiandrogens then GnRH only for severe high-risk specialist cases with monitoring — request for “kill sex drive” is not automatic indication for immediate GnRH without assessment of severity, alternatives, consent, and medical fitness.[2][3][4][5][6]

6. Monitoring and goals. Mood, behaviour logs, sexual side-effects of SSRIs; if androgen suppression used — metabolic, bone, cardiovascular, thromboembolic domains as relevant. Goals: stop nonconsensual acts, reduce urges/distress, restore function — not moral annihilation of all sexuality.[3][6]

References

  1. [1]Krueger RB, Reed GM, First MB, et al. Proposals for Paraphilic Disorders in the International Classification of Diseases and Related Health Problems, Eleventh Revision (ICD-11) Arch Sex Behav, 2017.PMID 28210933
  2. [2]Thibaut F, De La Barra F, Gordon H, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of paraphilias World J Biol Psychiatry, 2010.PMID 20459370
  3. [3]Thibaut F, Cosyns P, Fedoroff JP, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) 2020 guidelines for the pharmacological treatment of paraphilic disorders World J Biol Psychiatry, 2020.PMID 32452729
  4. [4]Assumpção AA, Garcia FD, Garcia HD, et al. Pharmacologic treatment of paraphilias Psychiatr Clin North Am, 2014.PMID 24877704
  5. [5]Garcia FD, Thibaut F Pharmacologic treatment of sex offenders with paraphilic disorder Curr Psychiatry Rep, 2013.PMID 23572328
  6. [6]Turner D, Briken P Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review J Sex Med, 2018.PMID 29289377
  7. [7]Seto MC The Motivation-Facilitation Model of Sexual Offending Sex Abuse, 2019.PMID 28715948